The Effects of Induced Polycystic Ovary Syndrome in NAG-1 Transgenic Mice

    January 2020 in “ ScholarWorks (Central Washington University) ”
    Nicholas Werner
    TLDR NAG-1 may help prevent some metabolic issues related to PCOS.
    The study investigated the effects of NAG-1 overexpression on metabolic disorders associated with polycystic ovary syndrome (PCOS) in mice. PCOS was induced in mice using dihydrotestosterone (DHT) implants, and the subjects were monitored for 90 days. The results showed that NAG-1 overexpression did not affect weight or adipocyte sizes, indicating a potential prevention of hormonally induced obesity. However, DHT-treated mice exhibited earlier puberty, disrupted estrus cycles, and altered ovarian function, with fewer corpus lutea observed. Overall, the findings suggested that NAG-1 might prevent some metabolic dysfunctions linked to PCOS.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results